INTRODUCTION
XRCC1 encodes a protein that functions in repair of single-strand breaks in DNA, presumably through its interactions with DNA ligase III (Lig III) (1, 2) and DNA polymerase β (Pol β) (3, 4) . The critical role of XRCC1 in the cellular response to DNA damage was found when the repair defects of certain mutant Chinese hamster ovary (CHO) cell lines were corrected by transfection with the human XRCC1 gene (5), cDNA (6) or with the purified XRCC1 polypeptide (7) . These CHO cell lines, EM7 (8) , EM9 (8) and EM-C11 (9) , comprise the known members of X-ray repair cross complementing group 1 (XRCC1). All cells in this group are characterized by hypersensitivity to (m)ethylation agents, sensitivity to ionizing radiation, accumulation of singlestrand breaks in DNA after damage and an unusually high frequency of sister chromatid exchange (SCE) (9, 10) . These characteristics appear to be unique among mammalian cell mutants. EM9 and EM-C11 cells were found to be deficient not only in XRCC1 protein (11) but also in Lig III (11, 12) , leading to the prediction that mutations in XRCC1 might destabilize the specific association between these two proteins (11) .
The probable participation of XRCC1 in base excision repair (BER) has been demonstrated by its interaction with proteins known to function in this pathway. In a reconstituted system for uracil removal using purified proteins, including Pol β and Lig III (3), addition of XRCC1 inhibited the strand displacement activity of Pol β, apparently limiting polymerization to 1 nt. However, these in vitro experiments indicated that XRCC1 was not essential for repair and no defect was seen in cellular extracts. Another base excision repair protein, poly(ADP-ribose) polymerase (PARP), which binds to nicks in DNA (13) , may also form a complex with XRCC1 (4) . Although it is not clear from these studies what the biochemical function of XRCC1 might be, it is apparent that in the XRCC1 complementation group a critical step is disabled during repair of some types of base damage. The notion that this compromised step is close to or coupled with ligation following repair synthesis is substantiated by the interaction between XRCC1 and Lig III and by a requirement for XRCC1 for Lig III stability (1, 2, 11, 14) .
The biological function of XRCC1 has also been examined in mouse. Along with Lig III and Pol β, XRCC1 appears to have a role in meiosis, as it is most highly expressed in mouse pachytene spermatocytes (15) . It is also essential for development, since mouse embryos lacking the Xrcc1 gene are unable to survive pastEven though there is no significant overall sequence homology between mammalian XRCC1 protein and known proteins from other organisms, a 90 amino acid peptide domain named after the BRCA1 C-terminus (BRCT) was identified in XRCC1, Lig III and also in PARP (17, 18) . The BRCT module appears to be a feature retained in many DNA damage response and cell cycle checkpoint proteins (17, 18) , such as human BRCA1, 53BP1, Saccharomyces cerevisiae Rad9 and Dpb11 and Schizosaccharomyces pombe rad4(cut5). A similar domain has been located in the interacting regions of the XRCC4 and DNA ligase IV proteins (19) .
Since mutant cell lines of the XRCC1 complementation group were classified by cellular hybridization studies and have not been related directly to alterations in the XRCC1 gene, we examined the status of XRCC1 mRNA, the coding sequence and protein product. During this study a new mutant cell line was characterized as a member of this complementation group. The entire collection of mutant cells were found to contain abnormal levels of XRCC1 protein, accompanied by point mutations in XRCC1 that directly affect DNA repair function.
MATERIALS AND METHODS

Cell culture
The origins of CHO lines AA8, CHO9 and their derivatives are given in Table 1 . Cultivation conditions were described previously (5) . The TOR hybridization/selective system described earlier (9) was used with polyethylene glycol-induced fusion of one doublemarked line (TOR, thioguanine-resistant and ouabain-resistant) to one unmarked line. A population of hybrids (>100 clones) was collected from each cross and then used to estimate survival following EMS exposure and to determine the modal chromosome number. 
Cell extracts
Total RNA was isolated from cell lines grown in T150 tissue culture flasks to 80% confluency. After discarding the culture medium cells were lysed directly in the flask with 5 ml denaturing solution (4 M guanidinium thiocyanate, 25 mM sodium citrate, pH 7, 0.1 M β-mercaptoethanol and 0.5% N-lauroylsarcosine) and processed as previously described (20) . Poly(A) + mRNA was isolated using the PolyATtract mRNA isolation system according to the manufacturer's instructions (Promega, Madison, WI). Isolated RNA was stored at -80_C as an ethanol precipitate. For genomic DNA isolation and protein extracts cells were trypsinized and washed with 10 mM sodium phosphate, pH 7.4, 150 mM NaCl (PBS). In the case of genomic DNA isolation pelleted cells from a T75 rotor at 90% confluency were resuspended in 2 ml digestion buffer (100 mM NaCl, 10 mM Tris-HCl, pH 8, 25 mM EDTA, 0.5% SDS and 0.1 mg/ml proteinase K) and processed as previously described (20) . For immunoblots cells were resuspended in 0.1 vol. 50 mM Tris-HCl, pH 8, 300 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 10% glycerol and lysed by sonication (3 × 30 s bursts at half power using a microtip) and cellular debris removed by centrifugation at 20 000 g. Cell extracts were stored in small aliquots at -80_C and used only once after thawing.
Irradiation
To estimate the sensitivity of the cell lines to X-ray exposure cells were irradiated in medium at a dose rate of 3 Gy/min (200 kV, 4 mA, 0.78 mm Al). For irradiation with UV light of 254 nm a Philips TUV germicidal lamp was used with a fluence rate of 0.19 W/m 2 , measured with an IL/770 germicidal radiometer.
Survival curves
Cultures in exponential growth were trypsinized and 300-3000 cells were plated, in duplicate, on 10 cm dishes and left to attach for 4 h. Cells were then either irradiated or treated with mitomycin C (MMC) or ethylmethane sulfonate (EMS) for 24 or 1 h respectively. After chemical treatment the medium was removed and cells were rinsed twice with PBS. Normal medium was then added and cells were incubated for 8-10 days. After incubation dishes were rinsed with NaCl (0.9%), air dried and stained with methylene blue (0.25%) and visible colonies counted. Each survival series was carried out at least three times for statistical evaluation.
Immunodetection
Protein extracts from CHO cell lines were separated by SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF) membrane using a blotting apparatus (BioRad Inc., Richmond, CA) at 20 V overnight. Protein molecular mass markers were detected using the S-tag system from Novagen Inc. (Madison, WI). XRCC1 protein was detected using a polyclonal antibody raised in mice against the human XRCC1 polypeptide, obtained by bacterial overexpression and purified as described previously (11) . The antibody was isolated by protein A affinity chromatography and further purified using a column containing immobilized S-peptide-XRCC1 fusion protein (Thelen, unpublished data). After washing the membrane a secondary anti-mouse IgG labeled with fluorescein isothiocyanate (FITC)-alkaline phosphatase (BioRad) was applied and processed for enhanced chemifluorescence using a Storm Phosphorimager (Molecular Dynamics Inc., Sunnyvale, CA). The scanned image was quantitated according to the manufacturer's instructions using background subtraction for each band representing XRCC1. At least four experiments were performed for each of the cell extracts.
RT-PCR and sequence determination
Hamster XRCC1 cDNAs were sequenced by a strategy employing direct sequencing of PCR products generated from cross-species RT-PCR. The cDNA was amplified in five overlapping segments to facilitate direct sequencing. Since the nucleotide sequence of the hamster XRCC1 cDNA was not known, PCR primers (Table 2) were directed to the most highly conserved regions of the mouse and human XRCC1 cDNAs and were chosen to match the mouse sequence. Most of the hamster XRCC1 cDNA coding sequence could be amplified in four PCR products. Once some hamster cDNA sequence was available, additional PCR primers were designed that amplified regions that could not be amplified previously with primers matching mouse sequences. 5′-RACE was performed to obtain the nucleotide sequence of the 5′-region of the XRCC1 cDNA. The 5′-RACE System (Life Technologies, Rockville, MD) was used according to the manufacturer's instructions. The unique PCR primers for 5′-RACE are listed in Table 2 . These unique primers were used along with the provided anchor primers for the 1_ and 2_ nested PCR reactions. Appended to the 5′-end of the PCR primers were DNA sequencing primer binding sites for the forward or reverse DYEnamic ET primers (Amersham Life Science, Cleveland, OH). First strand cDNA substrates for PCR were generated using an oligo(dT) primer and the Superscript Preamplification kit according to the manufacturer's instructions (Life Technologies). The first strand cDNA reactions were performed on 5 µg total RNA for all cell lines except for EM9, in which 500 ng poly(A) + RNA was used.
PCR reactions were performed in a 50 µl volume using a hot-start format. The final components of the reaction were as follows: 1× PCR buffer (10 mM Tris-HCl, pH 8.3 at 20_C, 1.5 mM MgCl 2 , 50 mM KCl), 200 mM each dNTP, 0.5 µM each primer, 1.25 U Taq DNA polymerase (Boehringer Mannheim, Indianapolis, IN) and 2 µl unpurified first strand cDNA product or 50 ng genomic DNA. All the reaction components except for Taq DNA polymerase were combined in a 40 µl volume. The reactions were then placed in a Perkin Elmer 9600 GeneAmp thermocycler and subjected to the following thermocycle conditions: initial denaturation at 94_C for 5 min (during which the Taq DNA polymerase in 10 µl 1× PCR buffer was added to the reaction mix); 35 cycles of denaturation at 94_C for 30 s, primer annealing at 63_C for 45 s and primer extension at 72_C for 1 min; a final incubation at 72_C for 7 min. PCR products were then analyzed in a 2% agarose gel containing 1× TAE buffer.
Prior to DNA sequencing the PCR reactions were digested with exonuclease I and calf intestinal alkaline phosphatase to remove excess primers and dNTPs (21) . We found that calf intestinal alkaline phosphatase substituted equally for shrimp alkaline phosphatase and saw no decrease in sequence quality. The PCR reactions (5 µl) were added to 5 µl digestion mix (containing 2.5 U exonuclease I and 2.5 U calf intestinal alkaline phosphatase in 10 mM Tris-HCl, pH 8.
Initial data analysis (lane tracking and base calling) was performed with the ABI prism DNA sequencing analysis software. Chromatograms generated by the ABI sequencing analysis software were then transfered to a Unix workstation and further analyzed with the Phred, Phrap and Consed programs. Base calls and quality values were set by Phred, sequences were assembled with Phrap and the resultant data was displayed with Consed (documentation is available through http://www. genome.washington.edu). Point mutations in the hamster XRCC1 cDNA and splice site sequence were identified by comparisons with the parental cell lines (AA8 or CHO9). 
RESULTS AND DISCUSSION
Mutant CHO cell lines forming the XRCC1 complementation group
To identify mutations within XRCC1 responsible for the defective DNA repair seen in CHO mutant cells, we analyzed the EMS-hypersensitive cell lines in the XRCC1 complementation group. Previous studies reported isolation of three mutants in this group (8) (9) (10) . As summarized in Table 1 , the mutants originated from two different CHO lines, AA8 and CHO9. Line EM9R1, an EMS-resistant phenotypic revertant of EM9, was derived by UV mutagenesis and EMS selection (23) .
A new EMS-sensitive mutant, EM-C12, was isolated from an N-ethyl-N-nitrosourea (ENU)-mutagenized population of CHO9 cells on the basis of its hypersensitivity to EMS, by replica plating as described earlier (24) . In the initial screen two clones, EMC-12a and EM-C12b, were isolated that maintained their EMS sensitivity for several months of continuous culture. Based on genetic complementation analyses (results not shown), these two cell lines were assigned to the EM-C11/EM9 complementation group. Nucleotide sequence data (see below) determined that EMC-12a and EM-C12b contained the same mutation and were apparently subclones of a single mutant, named here EM-C12.
EM-C12 was characterized by cell survival analysis for several DNA damaging agents (Fig. 1) . In comparison with the wild-type line, EM-C12 cells were only moderately sensitive to irradiation by UV and X-rays (1.5-and 1.7-fold sensitive at 37% survival respectively) and to exposure with the crosslinking agent MMC (1.8-fold sensitive). In contrast, these cells were 8-fold more sensitive to treatment with the alkylating agent EMS than the parental line, a level of sensitivity similar to mutant lines EM-C11 (9), EM7 and EM9 (5).
Absence of XRCC1 protein in mutant CHO cell extracts
The CHO cell lines listed in Table 1 were examined for the presence of XRCC1 protein by immunoblot analysis. Previous immunoblot experiments using a monoclonal antibody found no full-length protein in EM9 and EM-C11 cell extracts (11) . To increase detection sensitivity and also to observe any truncated XRCC1 polypeptides (i.e. multiple epitopes), we have produced a mouse polyclonal antibody specific for XRCC1. Using a high sensitivity fluorescence detection system we consistently observed the presence of XRCC1 protein in extracts from the repair-proficient cell lines, whereas neither full-length nor lower molecular weight forms of XRCC1 were detected in extracts from the repair-deficient mutant cells (Fig. 2A) . These results are consistent with the destabilizing effect of mutations in other proteins and, moreover, confirm the previous report of XRCC1 deficiency in EM9 and EM-C11 cells (11) . Quantification of the fluorescence signal indicated that the revertant EM9R1 cells contain a level of XRCC1 protein that is consistent with the wild-type AA8 and CHO9 cells (Fig. 2B) . 
Identification of mutations in the hamster XRCC1 coding sequence
To determine whether the phenotype that characterizes these CHO mutants arises from alterations in the XRCC1 cDNA, we sequenced the hamster XRCC1 ORF from each cell line by cross-species RT-PCR. Mutation analysis was simplified by the fact that CHO lines are hemizygous for XRCC1 (22) . As evidenced by the ability to obtain portions of the XRCC1 cDNA after reverse transcription of RNA from each cell line, the mutants are capable of expressing the XRCC1 gene. Sequence analysis revealed point mutations within the cDNAs of all the cell lines (Table 3 ) and these nucleotide changes result in significant alterations in the encoded amino acid sequence (Fig. 3) . EM-C12 cells contain a G!A substitution at nt 304, causing a Glu!Lys change at residue 102 (E102!K) and therefore altering the charge at that position from negative to positive (Fig. 3) . This Glu residue is strictly conserved in the mammalian homologs of XRCC1. Since this mutation is in the region of the XRCC1 protein demonstrated to interact with Pol β (3,4) , the negative charge in the native protein is likely to be crucial for protein-protein binding; alternatively, the change in charge may have a deleterious effect on XRCC1 protein folding and therefore also on protein-protein interactions.
The mutation found in EM-C11 cells, a G!A substitution at nt 1169, results in a C390!Y amino acid change. The Cys residue at this position, again strictly conserved in the mammalian XRCC1 homologs, is also conserved among many of the DNA repair and cell cycle checkpoint proteins containing the recently identified BRCT domain ( Fig. 3; 17,18 ). Substitution of a Cys, one of only six cysteines in XRCC1, could disrupt normal disulfide formation and result in incorrect protein folding. Moreover, replacing the sulfhydryl group of Cys with the bulky hydrophobic group of Tyr could alter protein folding. This is the first reported amino acid substitution in a BRCT domain that leads to a loss of DNA repair function, a phenomenon that would be predicted based on the widespread presence and the degree of conservation of this domain in DNA damage-responsive proteins (17, 18) .
Both BRCT modules are deleted from XRCC1 as a result of a C!T substitution found in EM9 cells. In this case the mutation at nt 661 introduces a termination codon TAG only one third of the way into the coding sequence and results in a truncated polypeptide of 220 residues (Fig. 3) . The C-terminal region of XRCC1, overlapping with the BRCT-b domain, is known to interact with Lig III (1,2), perhaps through a similar BRCT module located at the C-terminus of Lig III. XRCC1 protein only complexes with the longer of two alternatively spliced versions Figure 3 . Amino acid sequence alignment of hamster XRCC1 and mammalian homologs. Hamster (Cg) deduced amino acid sequence was compared with the mouse (Mm) and human (Hs) sequences using the ClustalW alignment program (29) and displayed here to indicate differences among sequences. …, residues identical with the hamster sequence; larger bold letters, sites of mutations in CHO cell lines, with the mutations found in each cell line given below. Annotations above the sequences indicate functional regions as described in the text. The hamster XRCC1 amino acid sequence is 90% identical to that of mouse and 84% to that of human.
of Lig III (2) , in which the BRCT domain is present, substantiating the notion that this sequence module in one protein might be interacting with a similar module in the other. Furthermore, the BRCT domain also appears to be necessary for an analogous interaction between DNA ligase IV and XRCC4, a double-strand break repair protein (19) . The critical nature of this sequence module can be seen by its loss due to a similar mutation, 1853Stop, in the human BRCA1 gene, leading to early onset breast cancer (25) .
In the revertant EM9R1 the mutant TAG originating from the EM9 cell line is changed to TTG (A!T at nt 662), thereby changing Stop221 to Leu. Although this results in an amino acid change at a strictly conserved Gln, Q221!L, the near normal SCE level in EM9R1 cells indicates that the mutant protein is fully functional (26) . The amount of XRCC1 protein detected in EM9R1 was comparable with that in AA8 cells (see Fig. 2B ), suggesting that Leu221 does not alter the stability of XRCC1 in vivo.
The final mutation in the XRCC1 complementation group was identified in genomic DNA from EM7 cells, in the putative splice site preceding exon 9. The first indication of a splicing abnormality was observed when multiple cDNA products of differing lengths were amplified from RNA of EM7. In this case an A!T substitution in the splice acceptor AG of XRCC1 intron 8 results in two different transcripts (EM7a and EM7b) containing short in-frame deletions in exon 9 and one out-of-frame transcript (EM7c) from splicing of exon 8 into exon 10 (Fig. 4) . These variants occur as a consequence of faulty RNA processing with cryptic splice acceptor sequences downstream. Once again, the mutation affects the BRCT-a module (see Fig. 3 ), causing complete loss of the Cys at residue 390 (discussed above) and also flanking amino acids such as Trp386, the most highly conserved residue in this domain (17, 18) .
In conclusion, all of the nucleotide sequence alterations identified here were found in the XRCC1 ORF. Each of the mutations results in a severe reduction in the level of XRCC1 protein and in the cellular capacity to repair strand breaks and certain kinds of base damage (9, 10) . It is likely that the primary result of these mutations is to destabilize XRCC1 through improper protein folding or through disruption of XRCC1-specific complex formation caused by alteration of critical contact residues. Complexes that are likely to be affected are between XRCC1 and Pol β, Lig III and perhaps PARP (see Fig. 3 ). Furthermore, disabled interactions between these proteins could destabilize more than one of the other complex partners, as appears to be the case where both XRCC1 and Lig III are absent in cells containing a mutation in XRCC1 (11) . Finally, the mutations in the BRCT-a domain of XRCC1 help to establish the biological significance of this sequence module.
